Onconetix, Inc. (ONCO)
2025-06-30 | 2025-03-31 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenue | 106,494 | 101,630 | 704,848 | |
| Cost of revenue | 35,991 | 55,798 | 604,132 | |
| Gross profit | 70,503 | 45,832 | 100,716 | |
| Impairment of intangible assets, indefinite-lived (excluding goodwill) | - | - | 1,237,140 | |
| Research and development | - | 24,455 | - | |
| Selling, general and administrative | 1,523,591 | 1,674,206 | 2,221,275 | |
| Impairment of goodwill | 594,000 | 10,918,000 | 10,261,000 | |
| Research and development | -111,670 | - | -3,680 | |
| Impairment of entadfi assets | - | - | - | |
| Total operating expenses | 2,005,921 | 12,616,661 | 13,715,735 | |
| Loss from operations | -1,935,418 | -12,570,829 | -13,615,019 | |
| Other income | - | - | -31,602 | |
| Investment income, investment expense | - | - | 205,146 | |
| Interest expense, debt | - | - | 156,169 | |
| Fair value of subscription agreement liability | - | - | 248,000 | |
| Other loss | -22,660 | -5,363 | - | |
| Interest expense - related party | - | - | - | |
| Interest expense | 223,097 | 223,592 | - | |
| Change in fair value of contingent warrant liabilities | 229 | 9,795 | - | |
| Gain on forgiveness of accounts payable | - | 944,694 | - | |
| Change in fair value of subscription agreement liability | -191,038 | 3,319,000 | - | |
| Total other (expense) income | -437,024 | 4,024,944 | -640,917 | |
| Loss before income taxes | -2,372,442 | -8,545,885 | -14,255,936 | |
| Income tax (expense) benefit | - | - | 50,768 | |
| Net loss | -2,372,442 | -8,545,885 | -14,306,704 | |
| Deemed dividend series c preferred stock | 328,504 | 1,170,091 | - | |
| Net loss applicable to common stockholders | -2,700,946 | -9,715,976 | -14,230,110 | |
| Other comprehensive income (loss), foreign currency translation adjustment, tax | - | - | -110,000 | |
| Change in pension benefit obligation | - | - | -33,406 | |
| Comprehensive income (loss), net of tax, attributable to parent | - | - | -14,230,110 | |
| Net loss per share, basic (in dollars per share) | -4.76 | -0.53 | -0.64 | |
| Net loss per share, diluted (in dollars per share) | -4.76 | -0.53 | -0.64 | |
| Weighted average number of common shares outstanding, basic (in shares) | 567,648 | 18,176,261 | 22,196,265 | |
| Weighted average number of common shares outstanding, diluted (in shares) | 567,648 | 18,176,261 | 22,196,265 | |